No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized TrialIsabelle Demeestere, Yvon Englert, Éric Van Den Neste et al.|Journal of Clinical Oncology|2016Cited by 241
Prediction of Severity of Symptoms in Iatrogenic Ovarian Hyperstimulation Syndrome by Follicle-Stimulating Hormone Receptor Ser<sup>680</sup>Asn PolymorphismCaroline Daelemans, Anne Delbaere, Guillaume Smits et al.|The Journal of Clinical Endocrinology & Metabolism|2004Cited by 134
Gonadotropin-Releasing Hormone Agonist for the Prevention of Chemotherapy-Induced Ovarian Failure in Patients With Lymphoma: 1-Year Follow-Up of a Prospective Randomized TrialIsabelle Demeestere, Yvon Englert, Pauline Brice et al.|Journal of Clinical Oncology|2012Cited by 121
Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome: role of early pregnancy and ovarian gonadotropin stimulationAnne Delbaere, Yvon Englert, Pierre J.M. Bergmann et al.|Fertility and Sterility|1997Cited by 40
Prorenin and active renin concentrations in plasma and ascites during severe ovarian hyperstimulation syndromeAnne Delbaere, Yvon Englert, Pierre Bergmann et al.|Human Reproduction|1997Cited by 33